Among the 13 patients with NSCLC who received chemotherapy, 5 received platinum-doublet + ICI(s), 3 received platinum-doublet, 4 received cytotoxic monotherapy, and 1 received EGFR-TKI. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.